SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Human & Experimental Toxicology
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by van Gelderen, C E M
Right arrow Articles by Savelkoull, T J F
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by van Gelderen, C E M
Right arrow Articles by Savelkoull, T J F
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Glycyrrhizic acid: the assessment of a no effect level

C E M van Gelderen

National Poisons Control Centre, National Institute of Public Health and the Environment, Bilthoven, Netherlands; Department of Intensive Care and Clinical Toxicology, Utrecht University Hospital, Utrecht, Netherlands; Vrijheid 1, 1231 TK Loosdrecht, Netherlands

J A Bijlsma

Department of Intensive Care and Clinical Toxicology, Utrecht University Hospital, Utrecht, Netherlands

W van Dokkum

TNO-Nutrition and Food Research, Zeist, Netherlands

T J F Savelkoull

National Poisons Control Centre, National Institute of Public Health and the Environment, Bilthoven, Netherlands; Department of Intensive Care and Clinical Toxicology, Utrecht University Hospital, Utrecht, Netherlands

Because from earlier experiments in rats and a pilot study in humans a no effect level of glycyrrhizic acid could not be established, a second experiment was performed in healthy volunteers. The experiment was performed in females only, because the effects were most marked in females in the pilot study. Doses of 0, 1, 2 and 4 mg glycyrrhizic acid/kg body weight were administered orally for 8 weeks to 39 healthy female volunteers aged 19-40 years.

The experimentlasted 12 weeks including an adaptation and a "wash-out" period.Ano-effectlevel of2 mg/kgis proposed from the results ofthis study, from which an acceptable daily intake (ADI) of 0.2 mg/kg body weight can be extrapolated with a safety factor of 10. This means consumption of 12 mg glycyrrhizic acid/day for a person with a body weight of 60 kg. This would be equal to 6 g licorice a day, assuming that licorice contains 0.2% of glycyrrhizic acid.

The proposed ADI is below the limit advised by the Dutch Nutrition Council of 200 mg glycyrrhizic acid/day. This reflects the relatively mild acute toxicity of glycyrrhizic acid, which is also emphasised by the "generally recognised as safe" (GRAS) status of glycyrrhizic acid in the USA in 1983. However, the long-term effects of a mild chronic intoxication (causing, for example, a mild hypertension), although not immediately lethal, justify special attention to the amount of glycyrrhizic acid used daily.

Key Words: glycyrrhizic acid • healthy volunteers • no-effect level • acceptable daily intake • atrial natriuretic peptide • renin-angiotensin-aldosterone axis

Human & Experimental Toxicology, Vol. 19, No. 8, 434-439 (2000)
DOI: 10.1191/096032700682694251


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
J. Am. Coll. Nutr.Home page
F. Aoki, K. Nakagawa, M. Kitano, H. Ikematsu, K. Nakamura, S. Yokota, Y. Tominaga, N. Arai, and T. Mae
Clinical Safety of Licorice Flavonoid Oil (LFO) and Pharmacokinetics of Glabridin in Healthy Humans
J. Am. Coll. Nutr., June 1, 2007; 26(3): 209 - 218.
[Abstract] [Full Text] [PDF]


Home page
International Journal of ToxicologyHome page
Final Report on the Safety Assessment of Glycyrrhetinic Acid, Potassium Glycyrrhetinate, Disodium Succinoyl Glycyrrhetinate, Glyceryl Glycyrrhetinate, Glycyrrhetinyl Stearate, Stearyl Glycyrrhetinate, Glycyrrhizic Acid, Ammonium Glycyrrhizate, Dipotassium Glycyrrhizate, Disodium Glycyrrhizate, Trisodium Glycyrrhizate, Methyl Glycyrrhizate, and Potassium Glycyrrhizinate
International Journal of Toxicology, March 1, 2007; 26(2_suppl): 79 - 112.
[Abstract] [Full Text] [PDF]



Advertisement